“We are looking for options for how we can keep the pace of the vaccine programme going given the news we’ve had” on restrictions to AstraZeneca and Johnson & Johnson vaccines, Stephen Donnelly told journalists.
“Certainly extending the interval for Pfizer beyond the four weeks is something that is being looked at,” he said. — Reuters